{
    "root": "35ac11af-34c3-0b96-e063-6294a90a228d",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Trazodone Hydrochloride",
    "value": "20250521",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "STARCH, PREGELATINIZED CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "TRAZODONE HYDROCHLORIDE",
            "code": "6E8ZO8LRNM"
        }
    ],
    "indications": "trazodone selective serotonin reuptake inhibitor indicated treatment major depressive disorder ( mdd ) ( 1 ) .",
    "contraindications": "starting dose : 150 mg divided doses daily . may increased 50 mg per day every three four days . maximum dose : 400 mg per day divided doses ( 2.1 ) . trazodone hydrochloride tablets taken shortly meal light snack ( 2.2 ) . tablets swallowed whole broken half along score line ( 2.2 ) . discontinued , gradual dose reduction recommended ( 2.6 ) .",
    "warningsAndPrecautions": "trazodone hydrochloride tablets usp , 100 mg white off-white , round-shape , biconvex beveled tablets , bisect one side plain side . bisected side tablet debossed ' 8 ' upper side bisect '06 ' lower side bisect supplied follows : ndcs 60760-806-60 bottles 60 60760-806-90 bottles 90 60760-806-30 bottles 30 - inactive store 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] . dispense child-resistant closure tight , light-resistant container .",
    "adverseReactions": "none ( 4 ) . concomitant monoamine oxidase inhibitors ( maois ) , within 14 days stopping maois ( 4 ) .",
    "indications_original": "Trazodone is a selective serotonin reuptake inhibitor indicated for the treatment of major depressive disorder (MDD) (1).",
    "contraindications_original": "Starting dose: 150 mg in      divided doses daily. May be increased by 50 mg per day every three to four      days. Maximum dose: 400 mg per day in divided doses (2.1). Trazodone hydrochloride tablets      should be taken shortly after a meal or light snack (2.2). Tablets should be swallowed      whole or broken in half along the score line (2.2). When discontinued, gradual dose      reduction is recommended (2.6).",
    "warningsAndPrecautions_original": "Trazodone Hydrochloride Tablets USP, 100 mg are white to off-white, round-shape, biconvex beveled tablets, bisect on one side and plain on other side. The bisected side of tablet is debossed with '8' on upper side of bisect and '06' on lower side of bisect and are supplied as follows:\n                  \n                  NDCs\n                  60760-806-60 BOTTLES OF 60\n                  60760-806-90 BOTTLES OF 90\n                  \n                  60760-806-30 BOTTLES OF 30 - INACTIVE\n                  \n                  \n                  \n                  Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].\n                  \n                  Dispense with a child-resistant closure in a tight, light-resistant container.",
    "adverseReactions_original": "None ( 4 ). Concomitant use of monoamine oxidase inhibitors (MAOIs), or use within 14 days of stopping MAOIs (4)."
}